Theralizumab (TGN1412) 是一种超级激动剂抗CD28单克隆抗体，可直接刺激 T 细胞。Theralizumab 可用于类风湿性关节炎的研究。
| 生物活性 | Theralizumab (TGN1412) is a superagonist anti-CD28monoclonal antibody that directly stimulates T cells. Theralizumab can be used for the research of rheumatoid arthritis[1][2]. |
| 性状 | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
